Cytokines: Their role in uveal disease

Eye

Volumn 11, Issue 2, 1997, Pages 200-205

  Kijlstra, Aize ^a,b  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cytokines; Uveitis

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 4;

CATARACT; CONFERENCE PAPER; EXPERIMENTAL MODEL; EYE INFLAMMATION; GLAUCOMA; IMMUNE RESPONSE; IMMUNOREGULATION; UVEA DISEASE;

EID: 0031011570     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.1997.51     Document Type: Conference Paper

References (58)

1. Thomson AW. The cytokine handbook, 2nd ed. San Diego: Academic Press, 1994.
2. Paul WE, Seder RA. Lymphocyte response and cytokines. Cell 1994;76:241.
3. Weiner HL, Freidman A, Miller A, Khoury SJ, al-Sabbagh A, Santos L, et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994; 12:809-37.
4. Saoudi A, Kuhn J, Huygen K, de Kozak Y, Velu T, Goldman M, et al. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur J Immunol 1993;23: 3096-103.
5. Calder VL, Hingorani M, Metz D, Buckley RJ, Lightman S. Differential expression of T cell cytokines in chronic allergic eye disease. Abstract book, Fourth International Symposium on Ocular Inflammation, London, UK 1996:34.
6. Cousins SW, McCabe MM, Danielpour D, Streilein W. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci 1990;32:2201-11.
7. Streilen J, Bradley D, Sano Y. Immunosuppressive properties of tissues of the ocular anterior segment. Ocul Immunol Inflamm 1996;4:57-68.
8. de Vos AF, Hoekzema R, Kijlstra A. Cytokines and uveitis: a review. Curr Eye Res 1992;11:581-97.
9. Chandler JW, Heise ER, Weiser RS. Induction of delayed-type sensitivity-like reactions in the eye by the injection of lymphokines. Invest Ophthalmol Vis Sci 1973;12:400-9.
10. Liu SH, Prendergast RA, Silverstein AM. The role of lymphokines in immunogenic uveitis. Invest Ophthalmol Vis Sci 1983;24:361-7.
11. Benson MT, Shepherd L, Rees RC, Rennie IG. Production of interleukin-6 by human retinal pigment epithelium in vitro and its regulation by other cytokines. Curr Eye Res 1992;11:173-9.
12. Kuppner MC, McKillop-Smith S, Forrester JV. TGF-β and IL-1β act in synergy to enhance IL-6 and IL-8 mRNA levels and IL-6 production by human retinal pigment epithelial cells. Immunology 1995;84:265-71.
13. Planck SR, Huang X-N, Robertson JE, Rosenbaum T. Retinal pigment epithelial cells produce interleukin-1 and granulocyte-macrophage colony-stimulating factor in response to interleukin-1. Curr Eye Res 1993; 3:205-12.
14. Elner VM, Strieter RM, Elner SG, Baggiolini M, Lindley I, Kunkel S. Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells. Am J Pathol 1990;136:745-50.
15. Einer SG, Stricter RM, Einer VM, Rollins BJ, Del Monte MA, Kunkel SL. Monocyte chemotactic protein gene expression by cytokine-treated human retinal pigment epithelial cells. Lab Invest 1991;64:819-25.
16. Jaffe GJ, Van Le L, Valea F, Haskill S, Roberts W, Arend WP, Stuart A, Peters WP. Expression of interleukin-1, interleukin-1 and an interleukin-1 receptor antagonist in human retinal pigment epithelial cells. Exp Eye Res 1992;55:325-35.
17. Rosenbaum JT, Samples JR, Hefeneider SH, Howes EL. Ocular inflammatory effects of intravitreal interleukin 1. Arch Ophthalmol 1987;105:1117-20.
18. Hoekzema R, Murray PI, Kijlstra A. Cytokines and intraocular inflammation. Curr Eye Res 1990;9:207-11.
19. Kulkarni PS, Srinivasan BD. Cachectin: a novel polypeptide induces uveitis in the rabbit eye. Exp Eye Res 1988;46:631-3.
20. Ferrick MR, Thurau SR, Oppenheim MH, Herbort CR, Ni M, Zachariae COC, et al. Ocular inflammation stimulated by intravitreal interleukin-8 and interleukin-1. Invest Ophthalmol Vis Sci 1991;32:1534-9.
21. Bhattacherjee P, Henderson B. Inflammatory responses to intraocularly injected interleukin 1. Curr Eye Res 1987;6:929-34.
22. de Vos AF, Klaren VNA, Kijlstra A. Expression of multiple cytokines and interleukin-1 receptor antagonist in the uvea and retina during endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci 1994; 35:3873-83.
23. de Vos AF, van Haren MAC, Verhagen C, Hoekzema R, Kijlstra A. Kinetics of intraocular tumour necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci 1994;35:1100-6.
24. Lang RA, Cuthbertson RA, Dunn AR. TNF alpha, IL-1 alpha and bFGF are implicated in the complex disease of GM-CSF transgenic mice. Growth Factors 1992;6:131-8.
25. Dvorak AM, Tepper RI, Weller PF, Morgan ES, Estrella P, Monahan-Earley RA, Galli SJ. Piecemeal degranulation of mast cells in the inflammatory eyelid lesions of interleukin-4 transgenic mice: evidence of mast cell histamine release in vivo by diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry. Blood 1994;83:3600-12.
26. Geiger K, Howes E, Gallina M, Huang XJ, Travis GH, Sarvetnick N. Transgenic mice expressing IFN-gamma in the retina develop inflammation of the eye and photoreceptor loss. Invest Ophthalmol Vis Sci 1994;35:2667-81.
27. Geiger K, Howes EL, Sarvetnick N. Ectopic expression of gamma interferon in the eye protects transgenic mice from intraocular herpes simplex virus type 1 infections. J Virol 1994;68:5556-67.
28. Egwuagu CE, Sztein J, Chan CC, Reid W, Mahdi R, Nussenblatt RB, Chepelinsky AB. Ectopic expression of gamma interferon in the eyes of transgenic mice induces ocular pathology and MHC class II gene expression. Invest Ophthalmol Vis Sci 1994;35:332-41.
29. Jones LS, Rizzo LV, Agarwal R, Silver PB, Caspi RR. Interferon gamma (IFN-γ) deficient mice are susceptible to induction of experimental autoimmune uveitis (EAU) [abstract]. Invest Ophthalmol Vis Sci 1996;37:S896.
30. Franks WA, Limb GA, Stanford MR, Ogilvie J, Wolstencroft RA, Chignell AH, Dumonde DC. Cytokines in human intraocular inflammation. Curr Eye Res 1992;11:187-91.
31. Wakefield D, Lloyd A. The role of cytokines in the pathogenesis of inflammatory eye disease. Cytokine 1992;4:1-5.
32. Murray PI, Hoekzema R, van Haren MAC, de Hon FD, Kijlstra A. Aqueous humor interleukin-6 levels in uveitis. Invest Ophthalmol Vis Sci 1990;31:917-20.
33. de Boer JH, van Haren MAC, de Vries-Knoppert WAEJ, Baarsma GS, de Jong PVTM, Postema FJ, et al. Analysis of IL-6 levels in human vitreous fluid obtained from uveitis patients, patients with proliferative intraocular disorders and eye bank eyes. Curr Eye Res 1992;11:181-6.
34. de Boer JH, Hack CE, Verhoeven AJ, Baarsma GS, de Jong PTVM, Rademakers AJ, et al. Chemoattractant and neutrophil degranulation activities related to interleukin-8 in vitreous fluid in uveitis and vitreoretinal disorders. Invest Ophthalmol Vis Sci 1993; 34:3376-85.
35. Mondino BJ, Sidikaro Y, Mayer FJ, Sumner HL. Inflammatory mediators in the vitreous humor of AIDS patients with retinitis. Invest Ophthalmol Vis Sci 1990;30:798-804.
36. 2 by lens epithelial cells of human cataracts. Br J Ophthalmol 1992;76:338-41.
37. van der Lelij A, Rothova A, de Vries JP, Vetter JCM, van Haren MAC, Stilma JS, Kijlstra A. Analysis of aqueous humour in ocular onchocerciasis. Curr Eye Res 1991;10:169-76.
38. Malecaze F, Chollet P, Cavrois E, Vita N, Arne JL, Ferrara P. Role of interleukin 6 in the inflammatory response after cataract surgery: an experimental and clinical study. Arch Ophthalmol 1991;109:1681-3.
39. Kauffmann DJ, van Meurs JC, Mertens DA, Peperkamp E, Master C, Gerritsen ME. Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1994; 35:900-6.
40. Baggiolini M, Dahinden CA. CC chemokines in allergic inflammation. Immunol Today 1994;15:127-33.
41. Einer SG, Einer VM, Jaffe GJ, Stuart A, Kunkel SL, Streiter RM. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr Eye Res 1995;14:1045-53.
42. Hooks JJ, Chan CC, Detrick B. Identification of the lymphokines, interferon-gamma and interleukin-2, in inflammatory eye diseases. Invest Ophthalmol Vis Sci 1988;29:1444-51.
43. Chan CC, Scott M, Whitcup MD, Solomon D, Nussenblatt RB. Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol 1995;120:671-3.
44. de Boer JH, Limpens J, Orengo-Nania S, de Jong PTVM, La Heij E, Kijlstra A. Low mature TGF-β2 levels in aqueous humor. Invest Ophthalmol Vis Sci 1994;35:3702-10.
45. Schultz MW, Chamberlain CG, McAvoy JW. Inhibition transforming growth factor-β-induced cataractous changes in lens explants by ocular media and α2-macroglobulin. Invest Ophthalmol Vis Sci 1996;37: 1509-19.
46. Arocker-Mettinger E, Asenbauer T, Ulbrich S, Grabner G. Serum interleukin 2-receptor levels in uveitis Curr Eye Res 1990;9:25-9.
47. Ben Ezra D, Maftzir G, Kalichman I, Barak V. Serum levels of interleukin-2 receptor in ocular Behçet's disease. Am J Ophthalmol 1993;115:26-30.
48. Limb GA, Chignell AH, Green W, Leroy F, Dumonde DC. Distribution of TNF-alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol 1996;80:168-73.
49. Suttorp-Schulten MSA, Jager MJ, Kijlstra A. Recent developments in the treatment of posterior uveitis. Ocul Immunol Inflamm 1996;4:207-17.
50. Nishi O, Nishi K, Ohmoto Y. Effect of interleukin 1 receptor antagonist on the blood-aqueous barrier after intraocular lens implantation. Br J Ophthalmol 1994;78:917-20.
51. Rosenbaum JT, Angell E. Paradoxical effects of IL-10 in endotoxin-induced uveitis. J Immunol 1995;155: 4090-4.
52. Ramanathan S, de Kozak Y, Saoudi A, Goureau O, van der Meide PH, Druet P, Bellon B. Recombinant IL-4 aggravates experimental autoimmune uveoretinitis in rats. J Immunol 1996;157:2209-15.
53. Röcken M, Racke M, Shevach EM. IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol Today 1996;17:225-31.
54. 2b for refractory ocular Behçet's disease. Lancet 1994;343:1428.
55. Caspi RR, Chan CC, Grubbs BG, Silver PB, Wiggert B, Parsa CF, Bahmanyar S, et al. Endogenous systemic IFN-gamma has a protective role against ocular autoimmunity in mice. J Immunol 1994;152:890-9.
56. Elliot MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis F. et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 1993; 36:1681-90.
57. Kasner L, Chan CC, Whitcup SM, Gery I. The paradoxical effect of tumor necrosis factor alpha (TNF-α) in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 1993;34:2911-7.
58. de Vos AF, van Haren MAC, Verhagen C, Hoekzema R, Kijlstra A. Systemic anti-tumor necrosis factor antibody treatment exacerbates endotoxin-induced uveitis in the rat. Exp Eye Res 1995;61:667-75.